Target intelligence / Profile preview

Neutrophil extracellular trap DNA scaffold (NET DNA)

Target
NET DNA
Molecular classification
Other (extracellular nuclear DNA/chromatin scaffold)
01

Overview

The NET DNA scaffold refers to the decondensed nuclear chromatin that forms the backbone of neutrophil extracellular traps (NETs). During NETosis, neutrophils extrude chromatin fibers (mainly DNA with histones and associated cytotoxic enzymes) into the extracellular space, where they function to trap and neutralize pathogens but can also promote inflammation, thrombosis, and tissue damage. This DNA scaffold is essential for immobilizing microbes, providing a structural base for localized high concentrations of toxic proteins, and serving as a stimulus for coagulation and inflammatory signaling. Excess or defective clearance of NET DNA scaffolds is implicated in autoimmunity, thrombosis, cancer progression, and a variety of inflammatory diseases[1][2][3][4][5][6][8].

Other names
NET DNANeutrophil extracellular trap DNANET scaffoldExtracellular DNA scaffold of NETs
02

Mechanism of action

DNase digests extracellular DNA scaffold, preventing NET-mediated trapping, thrombosis, and tissue injury. Heparin destabilizes the NET scaffold and increases its clearance. PAD4 inhibition prevents histone citrullination, thus inhibiting chromatin decondensation and NET formation.

03

Biological functions

Immune response (innate defense by trapping and neutralizing pathogens)Thrombosis (provides scaffold for clot formation)Inflammation (induces and promotes inflammation and tissue damage)Autoimmunity (can promote autoantigen exposure and self-reactivity)Modulation of cancer progression (remodeling of tumor microenvironment, awakening dormant cancer cells)
04

Disease associations

Infection (host defense against bacteria, fungi, and parasites)Thrombosis (promotes coagulation and platelet aggregation)Autoimmune disease (such as lupus, by providing sources of self-antigen)Cancer (involved in metastasis and cancer cell awakening)Inflammation (mediates tissue injury in inflammatory conditions)
05

Safety considerations

Targeting DNA indiscriminately could disrupt host defense and impair normal immune functionUnder-cleared NET DNA can promote autoimmunity, thrombosis, vascular damage, and severe inflammation
06

Interacting drugs

DNase (as a NET-dismantling therapy)

2 more in the full profile.

07

Biomarkers

Circulating extracellular DNACitrullinated histone H3Myeloperoxidase-DNA complexesNeutrophil elastase-DNA complexes

Beyond the preview

Go deeper on Neutrophil extracellular trap DNA scaffold (NET DNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neutrophil extracellular trap DNA scaffold (NET DNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call